CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 129 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $22,000 | -18.5% | 9,492 | 0.0% | 0.00% | – |
| Q4 2017 | $27,000 | +350.0% | 9,492 | +319.1% | 0.00% | – |
| Q3 2017 | $6,000 | 0.0% | 2,265 | 0.0% | 0.00% | – |
| Q2 2017 | $6,000 | -78.6% | 2,265 | -70.3% | 0.00% | – |
| Q1 2017 | $28,000 | -6.7% | 7,622 | -10.4% | 0.00% | – |
| Q4 2016 | $30,000 | -98.0% | 8,503 | -97.7% | 0.00% | -100.0% |
| Q3 2016 | $1,517,000 | -7.4% | 375,573 | +0.7% | 0.02% | -23.8% |
| Q2 2016 | $1,638,000 | +20.8% | 373,066 | +4.0% | 0.02% | +23.5% |
| Q1 2016 | $1,356,000 | -66.4% | 358,766 | +39.4% | 0.02% | -66.7% |
| Q4 2015 | $4,037,000 | +57.1% | 257,436 | +5.6% | 0.05% | +41.7% |
| Q3 2015 | $2,569,000 | +23254.5% | 243,784 | +54560.1% | 0.04% | – |
| Q2 2015 | $11,000 | -8.3% | 446 | 0.0% | 0.00% | – |
| Q1 2015 | $12,000 | -97.6% | 446 | -98.5% | 0.00% | -100.0% |
| Q2 2014 | $490,000 | – | 30,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,025,000 | $24,815,000 | 31.36% |
| TSP Capital Management Group, LLC | 836,342 | $20,248,000 | 8.80% |
| Iguana Healthcare Management, LLC | 200,000 | $4,842,000 | 2.76% |
| First Light Asset Management, LLC | 116,096 | $2,811,000 | 2.38% |
| SECTORAL ASSET MANAGEMENT INC | 2,227,688 | $53,932,000 | 2.33% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 550,735 | $13,334,000 | 2.05% |
| Eventide Asset Management | 257,000 | $6,222,000 | 1.92% |
| Redmile Group, LLC | 397,951 | $9,634,000 | 1.19% |
| ARDSLEY ADVISORY PARTNERS LP | 357,000 | $8,643,000 | 1.15% |
| Rhenman & Partners Asset Management AB | 90,000 | $2,179,000 | 0.85% |